Sumitomo Mitsui Trust Group
INSM icon

Sumitomo Mitsui Trust Group’s Insmed INSM Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82M Buy
501,282
+65,840
+15% +$10.1M 0.05% 326
2025
Q4 		$75.8M Buy
+435,442
New +$79.5M 0.04% 352

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sumitomo Mitsui Trust Group's INSM Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group increased its Insmed (INSM) stake by 15% in Q1 2026, buying an estimated $10.1M and bringing the position to 501,282 shares worth $82M. The position accounts for 0.05% of the portfolio, ranked #326.

Sumitomo Mitsui Trust Group first reported a position in INSM in Q4 2025 and has held it in 2 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 501,282 shares of Insmed worth $82M as of Q1 2026.
  • Sumitomo Mitsui Trust Group bought 65,840 Insmed shares in Q1 2026, an estimated $10.1M.
  • Insmed made up 0.05% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #326 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Insmed in Q4 2025 and has held it in 2 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.